Compare AbbVie Inc (ABBV) vs ARK Next Generation Internet ETF (ARKW) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbbVie Inc vs ARK Next Generation Internet ETF — how do they compare? AbbVie Inc trades at $253.68 (market cap $449.91B), while ARK Next Generation Internet ETF trades at $144.89. The key difference: AbbVie Inc pays a 2.72% dividend while ARK Next Generation Internet ETF pays none, and AbbVie Inc is trading nearer its 52-week high, ARK Next Generation Internet ETF nearer its low. Which is the better fit depends on your goals.
| ABBV | ARKW | |
|---|---|---|
Market Cap | $449.91B | — |
Sector | Health | Sector/Thematic |
52-Week High | $261.07 | $182.20 |
52-Week Low | $184.85 | $114.45 |
Enterprise Value | $513.38B | — |
Dividend Yield | 2.72% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbbVie (ABBV) trades at $252.92, down 0.72% on the day, with strong technical support at $251 and resistance at $258. The stock shows bullish momentum with recent earnings beats and a consensus analyst price target of $266.33. Revenue grew to $61.16B in 2025, though net margins compressed to 5.79%. Key growth drivers include Skyrizi and Rinvoq offsetting Humira declines, supported by positive Phase 2 data for ELAHERE in ovarian cancer (PRNewsWire, 2026-04-12).
Outlook remains positive with immunology portfolio strength and dividend growth, but risks include patent cliffs in the 2030s and high debt levels. Institutional buying and 68% analyst buy ratings suggest confidence, though valuation multiples like P/E of 124.83 warrant caution. Near-term catalysts include Q2 2026 earnings expected at $3.79 EPS.
ARKW is trading at $150.00, up 3.32% with strong technical momentum showing bullish moving averages and key indicators like ADX signaling upward trend strength. The stock faces resistance near $151-152 with support at $144-142. Recent news highlights ARK Invest's Cathie Wood sharing investments in Magnificent Seven stocks with Bill Ackman, indicating institutional confidence in growth-oriented technology holdings.
The ETF's exposure to innovative technology companies presents growth potential amid AI and digital transformation trends. Key risks include concentration in volatile tech sectors and market sensitivity to interest rate changes. Current technical strength suggests near-term upside potential if resistance levels are breached.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About ARK Next Generation Internet ETF
ARKW is an actively managed ETF that invests in next-generation internet technologies. It focuses on cloud computing, AI, e-commerce, and blockchain innovation, with key holdings like Tesla, Advanced Micro Devices, and Roku.
Read more on ARKW →
